Rostock International Parkinson's Disease Study (ROPAD)
Trial
N/A
Completed
April 12, 2026
Neuroimaging of Parkinson's
Trial
N/A
Recruiting
April 12, 2026
Effects of Physical Exercise Combined With Transcranial Direct Current Stimulation in Parkinson's Disease
Trial
N/A
Recruiting
April 12, 2026
Neurovascular Unit Dysfunction and Cerebral Small Vessel Disease in Parkinson Disease: A Systematic Review and a Meta Analysis.
Research
Neurology
April 9, 2026
Dysregulation of astrocytic DNAJC6 contributes to sporadic Parkinson's disease pathogenesis.
Research
The Journal of clinical investigation
April 9, 2026
Vestibulopathy as a Cause of Imbalance in Parkinson
Trial
Phase 1
Completed
April 8, 2026
Effects of Stimulation Patterns of Deep Brain Stimulation
Trial
N/A
Enrolling by invitation
April 8, 2026
Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy
Trial
N/A
Enrolling by invitation
April 8, 2026
Quantitative Imaging of Brain Glymphatic Function in Humans
Trial
Early Phase 1
Active, not recruiting
April 8, 2026
SPARX Clinical Trials-Reshaping Exercise and PD
News
Brian Grant Foundation
April 8, 2026
Meta analysis of glucose metabolism across Alzheimer's, Parkinson's and ALS Reveals emergence of adaptive brain glucometabolic responses and associated neurological functional profiles.
Research
medRxiv : the preprint server for health sciences
April 8, 2026
Pupil-light reflex in early-stage Parkinson's disease
News
SAGE Publications: Journal of Parkinson’s Disease: Table of Contents
April 7, 2026
Udall Project 1 Aim 4
Trial
N/A
Recruiting
April 7, 2026
Bacillus Subtilis in Parkinson's Disease
Trial
N/A
Completed
April 7, 2026
Etoricoxib in Patients With Parkinsonian Disease
Trial
Phase 2
Recruiting
April 7, 2026
CSF alpha-Synuclein Seed Amplification Assay results in routine clinically collected samples
News
SAGE Publications: Journal of Parkinson’s Disease: Table of Contents
April 7, 2026
Oxybutynin treatment for episodic hyperhidrosis in Parkinson disease.
Research
Journal of Parkinson's disease
April 7, 2026
CPAP for the Treatment of Supine Hypertension
Trial
N/A
Recruiting
April 6, 2026
Genetic and environmental risk factors of Parkinsonism.
Research
Journal of neural transmission (Vienna, Austria : 1996)
April 6, 2026
N-of-1 tissue activation modeling reveals regional subthalamic stimulation predicting verbal fluency decline in Parkinson disease.
Research
Journal of neural transmission (Vienna, Austria : 1996)
April 6, 2026